MARKET CONSULTATION | Solactive Pharma Breakthrough Value Index | January 2023
Solactive is inviting all stakeholders and interested third parties to evaluate the proposed changes to the Methodology for the “Solactive Pharma Breakthrough Value Index” and welcomes any feedback on how this may affect and/or improve their use of Solactive indices.
The detailed descriptions of the proposed changes can be found in the attached documents.
Stakeholders and third parties who are interested in participating in this Market Consultation, are invited to respond until January 30th, 2023 (cob).
Subject to feedback received on this Market Consultation, the changes mentioned above are intended to become effective on February 13th, 2023.